Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Pharmaceutical Statistics|March 24, 2021
Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methodsLuke Ondijo Ouma, Michael J Grayling, Haiyan Zheng, et al.
Contemporary Clinical Trials|April 11, 2025
Efficient stage-wise allocation ratios in multi-arm multi-stage designsRuqayya A Azher, Michael J Grayling, James M S Wason
Statistics in Medicine|January 22, 2022
Response adaptive intervention allocation in stepped-wedge cluster randomized trialsMichael J Grayling, James M S Wason, Sofía S Villar
Pharmaceutical Statistics|April 19, 2026
A Dose-Finding Design for Drug Combinations Using a Bayesian 4 Parameter Logistic Model With Penalised D-OptimalityMaxine Ajimi, Benjamin Webb, Graham M Wheeler, et al.
BMC Rheumatology|December 7, 2021
Increasing power in the analysis of responder endpoints in rheumatology: a software tutorialMartina McMenamin, Michael J Grayling, Anna Berglind, et al.
BMC Medical Research Methodology|December 20, 2023
A Bayesian approach to pilot-pivotal trials for bioequivalence assessmentDuo Lv, Michael J Grayling, Xinyue Zhang, et al.
JCO Precision Oncology|January 5, 2024
Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future ProspectsZhulin Yin, Adrian P Mander, Johann S de Bono, et al.
Pharmaceutical Statistics|January 11, 2012
Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesisAdrian P Mander, James M S Wason, Michael J Sweeting, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|January 13, 2023
Bayesian modelling strategies for borrowing of information in randomised basket trialsLuke O Ouma, Michael J Grayling, James M S Wason, et al.
Pageof 10